Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery

This study is not yet open for participant recruitment.

Study NCT00700882 Information provided by National Cancer Institute (NCI)

First Received: June 18, 2008 Last Updated: March 7, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is not yet open for participant recruitment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	March 2013 (Final data collection date for primary outcome measure)